3/14/2014 9:51:08 AM
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today announced the appointments of Alfred F. Altomari and Dr. Michael Berelowitz to the Company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by